INNOVATION PHARMACEUTICALS INC. Accounts Payable
INNOVATION PHARMACEUTICALS INC. had Accounts Payable of $3.02 million as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2023-11-20
- 2023-09-30: Accounts Payable, Current $3.02M.
- 2023-06-30: Accounts Payable, Current $2.98M.
- 2023-03-31: Accounts Payable, Current $2.70M.
- 2022-12-31: Accounts Payable, Current $2.70M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2023-09-30 | $3.02M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $2.98M 10-Q · filed 2023-11-20 | |
| 2023-03-31 | $2.70M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.70M 10-Q · filed 2023-02-15 | |
| 2022-09-30 | $2.92M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.57M 10-K · filed 2023-09-28 | |
| 2022-03-31 | $2.40M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $2.30M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $2.34M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $2.56M 10-K · filed 2022-09-28 | |
| 2021-03-31 | $2.05M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.98M 10-Q · filed 2021-02-22 | |
| 2020-09-30 | $2.17M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $2.04M 10-K · filed 2021-09-27 | |
| 2019-06-30 | $2.13M 10-K · filed 2020-09-14 | |
| 2019-03-31 | $2.25M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $2.45M 10-Q · filed 2019-02-08 | |
| 2018-09-30 | $2.79M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $3.19M 10-Q · filed 2019-05-10 | |
| 2018-03-31 | $4.12M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.85M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $5.41M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $4.70M 10-K · filed 2018-09-11 | |
| 2017-03-31 | $4.19M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $3.22M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $3.72M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $3.53M 10-K · filed 2017-09-11 | |
| 2016-03-31 | $3.12M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $2.10M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $2.06M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.84M 10-K · filed 2016-09-13 | |
| 2015-03-31 | $2.05M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $2.08M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $2.26M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $2.66M 10-K · filed 2015-09-11 | |
| 2014-03-31 | $1.82M 10-Q/A · filed 2014-05-16 | |
| 2013-12-31 | $1.78M 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $1.83M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $1.85M 10-K · filed 2014-09-15 | $1.85M 10-K · filed 2013-09-30 |
| 2013-03-31 | $1.98M 10-Q · filed 2013-05-20 | |
| 2012-12-31 | $1.99M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $1.87M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $1.97M 10-K · filed 2013-09-30 | |
| 2012-03-31 | $2.00M 10-Q · filed 2012-05-18 | |
| 2011-12-31 | $2.04M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $1.92M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $2.14M 10-K · filed 2012-10-12 |